Concepedia

Florian Brockhaus

FB

Statistics

Publications

15

Citations

1.1K

H-Index

12

Active since

1991

Affiliations

Novartis (Switzerland)(Current)

Friedrich-Alexander-Universität Erlangen-Nürnberg

Novartis (United States)

Nemours Children's Clinic

Rainbow Babies & Children's Hospital

Florian Brockhaus is an author at Novartis (Switzerland) specializing in medicine, apoptosis, and cell death.

Top concepts

Publications per year

1991–2020

15

Publications

15

Safety, efficacy and convenience of tobramycin inhalation powder in cystic fibrosis patients: The EAGER trial

Michael W. Konstan, Patrick A. Flume, Matthias Kappler et al. · Journal of Cystic Fibrosis · 2010 · 310 citations · Full text

, , +3

Tobramycin inhalation powder for <i>P. aeruginosa</i> infection in cystic fibrosis: The EVOLVE trial

Michael W. Konstan, David E. Geller, Predrag Minić et al. · Pediatric Pulmonology · 2010 · 164 citations

Fevipiprant, an oral prostaglandin DP<sub>2</sub>receptor (CRTh2) antagonist, in allergic asthma uncontrolled on low-dose inhaled corticosteroids

Eric D. Bateman, Alfredo G. Guerreros, Florian Brockhaus et al. · European Respiratory Journal · 2017 · 102 citations · Full text

Effectiveness of fevipiprant in reducing exacerbations in patients with severe asthma (LUSTER-1 and LUSTER-2): two phase 3 randomised controlled trials

Christopher E. Brightling, Mina Gaga, Hiromasa Inoue et al. · The Lancet Respiratory Medicine · 2020 · 95 citations

, , +7

U937 Apoptotic Cell Death by Nitric Oxide: Bcl-2 Downregulation and Caspase Activation

Florian Brockhaus, Bernhard Brüne · Experimental Cell Research · 1998 · 89 citations

, , +10

1–5 of 15